Why Karuna Therapeutics Stock Is Soaring Again Today
Shares of Karuna Therapeutics (NASDAQ: KRTX) were up 50% higher as of 11:03 a.m. EST on Tuesday. This marked the second day of big gains for the clinical-stage biopharmaceutical company. Karuna's stock more than tripled on Monday after the company announced great results from a phase 2 clinical study of its experimental schizophrenia drug KarXT.
Some good news is so good that it takes a while for the market to completely process it. That's what we're seeing with Karuna's clinical update.
Image source: Getty Images.
Source Fool.com
